Stay updated on Cabozantinib for NSCLC Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for NSCLC Brain Metastases Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page’s footer software/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” with no associated changes to the underlying study information.
    Difference
    0.1%
    Check dated 2026-04-24T05:40:42.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:20:39.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0. No visible changes to the study details page or layout.
    Difference
    0.1%
    Check dated 2026-03-18T21:16:36.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. No user-facing changes to study details or page functionality are introduced.
    Difference
    0.1%
    Check dated 2026-03-11T19:09:28.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    No substantive content changes were detected. The page appears to have only visual/layout adjustments without altering study details.
    Difference
    0.1%
    Check dated 2026-02-25T09:24:13.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2 and the older notices about funding and v3.4.1 have been removed; these are administrative updates that do not affect the trial’s content or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:25:33.000Z thumbnail image

Stay in the know with updates to Cabozantinib for NSCLC Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.